The roles of osteocyte signaling in bone

Journal of the American Academy of Orthopaedic Surgeons

Volumn 20, Issue 10, 2012, Pages 670-671

  Kennedy, Oran D ^a   Schaffler, Mitchell B ^a  

^a City College of New York   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE; CYTOLOGY; HUMAN; OSTEOCYTE; PHYSIOLOGY; REVIEW; SIGNAL TRANSDUCTION;

BONE AND BONES; HUMANS; OSTEOCYTES; SIGNAL TRANSDUCTION;

EID: 84868244245     PISSN: 1067151X     EISSN: None     Source Type: Journal    
DOI: 10.5435/JAAOS-20-10-670     Document Type: Article

References (7)

1. Feng JQ, Ward LM, Liu S, et al: Loss of DMP1 causes rickets and osteomalacia and identifies a role for osteocytes in mineral metabolism. Nat Genet 2006;38(11):1310-1315. (Pubitemid 44646294)
2. Liu S, Zhou J, Tang W, Jiang X, Rowe DW, Quarles LD: Pathogenic role of Fgf23 in Hyp mice. Am J Physiol Endocrinol Metab 2006;291(1):E38-E49. (Pubitemid 44035308)
3. Poole KE, Van Bezooijen RL, Loveridge N, et al: Sclerostin is a delayed secreted product of osteocytes that inhibits bone formation. FASEB J 2005;19(13):1842-1844. (Pubitemid 41598769)
4. Tanaka-Kamioka K, Kamioka H, Ris H, Lim SS: Osteocyte shape is dependent on actin filaments and osteocyte processes are unique actin-rich projections. J Bone Miner Res 1998;13(10):1555-1568. (Pubitemid 28465296)
5. Cardoso L, Herman BC, Verborgt O, Laudier D, Majeska RJ, Schaffler MB: Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue. J Bone Miner Res 2009;24(4):597-605.
6. Kennedy OD, Herman BC, Laudier DM, Majeska RJ, Sun HB, Schaffler MB: Activation of resorption in fatigueloaded bone involves both apoptosis and active pro-osteoclastogenic signaling by distinct osteocyte populations. Bone 2012;50(5):1115-1122.
7. Cheng Y, Deshmukh M, D'Costa A, et al: Caspase inhibitor affords neuroprotection with delayed administration in a rat model of neonatal hypoxic-ischemic brain injury. J Clin Invest 1998;101(9):1992-1999. (Pubitemid 28226119)